Antipodes Partners’s Sabre SABR Stock Holding History

Antipodes Partners’s Portfolio SABR Stock Details SABR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-87,855	Closed	-$278K	–	133
2025 Q2	$278K	Buy	+87,855	New	+$225K	0.01%	60

Other funds holding SABR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Discerene Group Stamford, Connecticut $946M AUM 1.38% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

OHA

Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Antipodes Partners's SABR Position: Q3 2025 in Review

Antipodes Partners sold out of Sabre (SABR) in Q3 2025, closing a stake of 87,855 shares — an estimated $278K sold.

Antipodes Partners first reported a position in SABR in Q2 2025 and held it in 1 quarter. The position peaked at $278K in Q2 2025. 249 funds tracked by Wall St. Rank hold SABR as of Q3 2025.

Antipodes Partners reported no remaining Sabre position as of Q3 2025 after selling out during the quarter.
Antipodes Partners sold 87,855 Sabre shares in Q3 2025, an estimated $278K.
Antipodes Partners first reported a position in Sabre in Q2 2025 and held it in 1 quarter.
Antipodes Partners's Sabre position peaked at $278K in Q2 2025.
249 funds tracked by Wall St. Rank held Sabre as of Q3 2025.

Based on Antipodes Partners's 13F filing for Q3 2025, filed 10 Nov 2025.